Entity

Time filter

Source Type

Nantes, France

The University of Nantes is a French university, located in the city of Nantes. In addition to the several campuses scattered in the city of Nantes, there are two satellite campuses located respectively in Saint-Nazaire and La Roche-sur-Yon. Currently, the University is attended by approximately 34,500 students. More than 10% of them are international students coming from 110 countries.The University of Nantes was ranked between 600-650th in the QS World University Rankings of 2013. On a national scale and regarding the professional insertion after graduation, the University of Nantes oscillates between the ranks 3rd and 40th out of 69 universities depending on the field of studies. On overall, the university is ranked 45th out of 76 universities in France. Among its noticeable alumni are the former French Prime Minister Jean-Marc Ayrault as well as one of the French Ministers of Agriculture. Wikipedia.


Patent
Institute Pasteur Paris, French National Center for Scientific Research, French Institute of Health, Medical Research and University of Nantes | Date: 2014-01-20

The invention relates to a genetically modified infectious measles virus derived from a live-attenuated measles virus strain, in which the gene encoding the viral accessory C protein has been knocked out (MV-deltaC). It concerns in particular the use of said genetically modified infectious MV-deltaC in the treatment of malignant tumour or cancer conditions, and for the preparation of agents or compositions for such treatment.


Patent
French National Center for Scientific Research and University of Nantes | Date: 2014-01-06

The device for electrochemically synthesizing intermediate species of a chemical entity which comprises an electrochemical oxidation cell including a first working electrode and a first counter electrode, capable, when these first electrodes are subject to an electric potential, of generating the intermediate species by oxidation of a solution introduced into the electrochemical oxidation cell and comprising the chemical entity, and an electrochemical stabilization cell including a second working electrode and a second counter electrode respectively distinct from the first working electrode and counter electrode, capable, when these second electrodes are subject to an electric potential, of achieving reduction of a solution. The stabilization cell is connected in series to the oxidation cell so as to allow continuous reduction of the intermediate species generated in the oxidation cell. Applications can be in the pharmaceutical, agri-food and environment fields.


Patent
Thales Alenia and University of Nantes | Date: 2015-09-01

The invention relates to a method for determining by optimization a multi-core architecture and a way of implementing an application on the architecture for a given application, the method comprising:


Patent
French Institute of Health, Medical Research, French National Center for Scientific Research and University of Nantes | Date: 2013-03-01

The present invention relates to a use of at least one glycosylated tetrafunctional amphiphilic block copolymer, as immune adjuvant.


The monoclonal antibodies that only recognise the O-acetylated form of the GD2 ganglioside, or fragments of the antibody, for the diagnosis and the treatment of cancers in which the cells express the O-acetylated GD2, the antibody or the fragment recognising the O-acetylated GD2 molecules expressed by the tumoral cells and not recognising the GD2 molecules expressed at the surface of the peripheral nerves, in order to increase the specificity of the diagnosis and reduce the toxicity of the treatments. Also artificially modified antibodies advantageously used for treating and diagnosing cancers in which the cells express the O-acetylated GD2.

Discover hidden collaborations